Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Cash from Operations (2016 - 2025)

HealthLynked (HLYK) has disclosed Cash from Operations for 10 consecutive years, with 444291.0 as the latest value for Q3 2025.

  • On a quarterly basis, Cash from Operations rose 57.15% to 444291.0 in Q3 2025 year-over-year; TTM through Sep 2025 was 2037982.0, a 48.31% increase, with the full-year FY2024 number at 3494122.0, up 15.7% from a year prior.
  • Cash from Operations was 444291.0 for Q3 2025 at HealthLynked, down from 417536.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 634168.0 in Q3 2021 to a low of 2142670.0 in Q4 2021.
  • A 5-year average of 861956.53 and a median of 858694.0 in 2024 define the central range for Cash from Operations.
  • Peak YoY movement for Cash from Operations: surged 12015.97% in 2021, then tumbled 1444.28% in 2023.
  • HealthLynked's Cash from Operations stood at 2142670.0 in 2021, then skyrocketed by 104.14% to 88694.0 in 2022, then crashed by 1444.28% to 1192294.0 in 2023, then skyrocketed by 37.63% to 743602.0 in 2024, then surged by 40.25% to 444291.0 in 2025.
  • Per Business Quant, the three most recent readings for HLYK's Cash from Operations are 444291.0 (Q3 2025), 417536.0 (Q2 2025), and 432553.0 (Q1 2025).